|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$96,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$2,129,320
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
$6,367
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
$16,677
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
$18,339
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$93,060
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$123,492
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S6
|
$265,465
|
$21,237
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
$240,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$101,162
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$750
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$1,227
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-20
|
$4,071,218
|
$407,122
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
1R01CA182633-01
|
$704,800
|
$704,800
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$2,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$3,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Iowa Oncology Research Association
|
3U10CA035101-28S1
|
$123,717
|
$3,712
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-32S1
|
$75,000
|
$6,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-32
|
$2,459,346
|
$196,748
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
3U10CA063844-20S1
|
$100,152
|
$3,005
|
BERENBERG, JEFFREY
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Optimization of bifunctional pharmacophores for the treatment of neuroblastoma.
|
1R43CA180264-01A1
|
$225,000
|
$225,000
|
BETTOUN, DAVID
|
HARO PHARMACEUTICAL, INC.
|
|
Optimization of bifunctional pharmacophores for the treatment of neuroblastoma.
|
3R43CA180264-01A1S1
|
$25,000
|
$25,000
|
BETTOUN, DAVID
|
HARO PHARMACEUTICAL, INC.
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
5U01CA168426-03
|
$1,165,605
|
$1,165,605
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
National Center: Multiscale Analysis of Genomic and Cellular Networks (MAGNet)
|
5U54CA121852-10
|
$3,589,179
|
$287,134
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA082103-16S2
|
$49,999
|
$1,000
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-16S3
|
$74,999
|
$1,500
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-16
|
$7,049,997
|
$141,000
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Validating the prognostic value of EGFR768 in neuroblastoma
|
1R21CA187554-01
|
$169,711
|
$169,711
|
CHAN, EDWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Investigating the tumor suppressive functions of the miR-34 family of microRNAs
|
5F31CA168356-02
|
$42,676
|
$21,338
|
CONCEPCION, CARLA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Perinatal, Familial, and Neighborhood Risk Factors for Childhood Cancer
|
5R03CA171017-02
|
$48,190
|
$4,819
|
CRUMP, CASEY
|
LUND UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$749
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$15,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
MYC--Transcription and Apoptosis
|
2R01CA051497-23A1
|
$456,800
|
$228,400
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$2,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$223,491
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-07
|
$232,069
|
$232,069
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-04
|
$473,452
|
$345,620
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Copy number variations (CNVs) in neuroblastoma
|
5R00CA151869-05
|
$229,071
|
$229,071
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-05
|
$287,576
|
$287,576
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma
|
5R01CA172067-02
|
$323,237
|
$323,237
|
DUBOIS, STEVEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
2R01CA057138-23A1
|
$589,250
|
$294,625
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Nevada Cancer Research foundation-Community Clinical Oncology Program
|
3U10CA035421-30S1
|
$113,166
|
$3,395
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$143,876
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S1
|
$125,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S2
|
$50,000
|
$2,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S3
|
$320,000
|
$12,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S4
|
$75,000
|
$3,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Neuroblastoma for this search: $23,581,708
|